Canada · Delayed Price · Currency is CAD Genix Pharmaceuticals Company Description
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada.
The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops.
It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism.
The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019.
Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.
| Country | Canada |
| Founded | 1993 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4,000 |
| CEO | Sina Pirooz |
Contact Details
Address: 1055 West Hastings Street Vancouver, BC V6E 2E9 Canada | |
| Phone | 604-609-6198 |
| Website | genixpharm.com |
Stock Details
| Ticker Symbol | GENX |
| Exchange | TSX Venture Exchange |
| Fiscal Year | November - October |
| Reporting Currency | CAD |
| ISIN Number | CA37232A1093 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sina Salehi Pirooz | Chief Executive Officer and Director |
| Mahmoud S. Aziz | Chairman of the Board and President |
| Wayne Kent Lee CA, CPA | Chief Financial Officer |
| Kevin James Bottomley | Director of Corporate Development and Independent Director |